1. Home
  2. EXEL vs PEGA Comparison

EXEL vs PEGA Comparison

Compare EXEL & PEGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • PEGA
  • Stock Information
  • Founded
  • EXEL 1994
  • PEGA 1983
  • Country
  • EXEL United States
  • PEGA United States
  • Employees
  • EXEL N/A
  • PEGA N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • PEGA EDP Services
  • Sector
  • EXEL Health Care
  • PEGA Technology
  • Exchange
  • EXEL Nasdaq
  • PEGA Nasdaq
  • Market Cap
  • EXEL 9.4B
  • PEGA 9.3B
  • IPO Year
  • EXEL 2000
  • PEGA 1996
  • Fundamental
  • Price
  • EXEL $36.85
  • PEGA $77.89
  • Analyst Decision
  • EXEL Buy
  • PEGA Buy
  • Analyst Count
  • EXEL 18
  • PEGA 12
  • Target Price
  • EXEL $37.24
  • PEGA $100.17
  • AVG Volume (30 Days)
  • EXEL 2.5M
  • PEGA 1.1M
  • Earning Date
  • EXEL 02-11-2025
  • PEGA 02-12-2025
  • Dividend Yield
  • EXEL N/A
  • PEGA 0.15%
  • EPS Growth
  • EXEL 170.77
  • PEGA 50.76
  • EPS
  • EXEL 1.76
  • PEGA 1.11
  • Revenue
  • EXEL $2,168,701,000.00
  • PEGA $1,497,180,000.00
  • Revenue This Year
  • EXEL $5.36
  • PEGA $7.67
  • Revenue Next Year
  • EXEL $10.59
  • PEGA $7.57
  • P/E Ratio
  • EXEL $20.87
  • PEGA $70.44
  • Revenue Growth
  • EXEL 18.49
  • PEGA 4.51
  • 52 Week Low
  • EXEL $20.14
  • PEGA $54.55
  • 52 Week High
  • EXEL $37.59
  • PEGA $113.67
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 65.59
  • PEGA 24.39
  • Support Level
  • EXEL $34.01
  • PEGA $81.86
  • Resistance Level
  • EXEL $35.46
  • PEGA $86.58
  • Average True Range (ATR)
  • EXEL 1.09
  • PEGA 4.00
  • MACD
  • EXEL 0.36
  • PEGA -3.36
  • Stochastic Oscillator
  • EXEL 95.70
  • PEGA 0.44

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About PEGA Pegasystems Inc.

Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management, or BPM, with customer relationship management, or CRM, applications. The company focuses on enterprise-size customers, specifically within the financial, insurance, and healthcare fields.

Share on Social Networks: